BELLUOMINI, Lorenzo
 Distribuzione geografica
Continente #
NA - Nord America 291
EU - Europa 88
AS - Asia 80
SA - Sud America 10
AF - Africa 1
OC - Oceania 1
Totale 471
Nazione #
US - Stati Uniti d'America 289
IT - Italia 39
CN - Cina 31
SG - Singapore 31
DE - Germania 14
BR - Brasile 10
ID - Indonesia 8
FI - Finlandia 7
IE - Irlanda 7
BE - Belgio 5
GB - Regno Unito 4
TR - Turchia 4
UA - Ucraina 4
SE - Svezia 3
CA - Canada 2
IN - India 2
NL - Olanda 2
AT - Austria 1
AU - Australia 1
BD - Bangladesh 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
IQ - Iraq 1
KZ - Kazakistan 1
MA - Marocco 1
OM - Oman 1
Totale 471
Città #
Chandler 34
Santa Clara 29
Ashburn 27
Fairfield 27
Singapore 26
New York 17
Woodbridge 16
Houston 15
Ann Arbor 12
Milan 11
Seattle 9
Wilmington 9
Jakarta 8
Shanghai 8
Dublin 7
Ferrara 7
Helsinki 7
Jacksonville 7
Princeton 6
Beijing 5
Brussels 5
Cambridge 5
Bologna 4
Bremen 4
Izmir 4
Boardman 3
Falkenstein 3
Ferrara di Monte Baldo 3
Los Angeles 3
Munich 3
São Paulo 3
Hebei 2
Hyderabad 2
Nanchang 2
Nanjing 2
Pasadena 2
Verona 2
Agna 1
Almaty 1
Baghdad 1
Brno 1
Catania 1
Changsha 1
Curitiba 1
Descalvado 1
Falls Church 1
Frankfurt am Main 1
Jaguaruna 1
Jiaxing 1
Kunming 1
London 1
Manassas 1
Mountain View 1
Muscat 1
Olinda 1
Ottawa 1
Parma 1
Pedro II 1
Rabat 1
Redwood City 1
Rome 1
San Diego 1
São Gonçalo 1
Toronto 1
Uberlândia 1
Volketswil 1
Totale 368
Nome #
Patients with NSCLC may display a low ratio of p.T790M vs. activating EGFR mutations in plasma at disease progression: Implications for personalised treatment 133
Estrogen receptor mutation: a new strategy to overcome endocrine resistance 79
Immune Checkpoint Inhibitor Nivolumab and Radiotherapy in Pretreated Lung Cancer Patients: Efficacy and Safety of Combination 62
Can irinotecan dose reduction according to ugt1a1 genotype avoid severe toxicities? 54
Immune Checkpoint Inhibitors and Radiotherapy in NSCLC Patients: Not Just a Fluke 47
A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC 46
Monitoring Somatic Genetic Alterations in Circulating Cell-Free DNA/RNA of Patients with "Oncogene-Addicted" Advanced Lung Adenocarcinoma: A Real-World Clinical Study 44
Abscopal effect and resistance reversion in nivolumab-treated non-small-cell lung cancer undergoing palliative radiotherapy: a case report 24
Totale 489
Categoria #
all - tutte 4.455
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.455


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202018 0 0 0 0 0 0 0 2 4 7 1 4
2020/202151 4 2 1 4 3 4 3 6 8 7 4 5
2021/202250 2 0 0 2 1 5 5 5 5 5 4 16
2022/202393 8 4 14 6 20 10 6 11 11 0 2 1
2023/202470 4 8 0 0 2 25 3 8 0 3 0 17
2024/2025123 5 9 20 14 28 28 13 6 0 0 0 0
Totale 489